Lucas Lee is a seasoned professional in the bioanalytical and drug development field, currently serving as a Senior Bioanalytical Scientist at QPS Holdings, LLC since August 2021. Leading a research and development team, Lucas oversees GLP-compliant bioanalytical and DMPK studies for various pharmaceutical companies, with a focus on preclinical LC-MS/MS method development and PK/PD data interpretation. Previously, Lucas held the position of Bioanalytical Lead at Agios Pharmaceuticals, contributing significantly to high-profile projects such as the NDA for TIBSOVO® and the development of large molecule quantitation platforms. Prior roles include Senior Scientist at Takeda Pharmaceuticals America, where LC-MS/MS methods for small molecule drugs were developed and validated, and Program Manager at Takeda Pharmaceuticals in Taiwan. Lucas began a career as a Scientist at Cereon Genomics, focusing on high-throughput metabolite profiling. Educational qualifications include a Master of Science in Biological Sciences from Harvard University.
This person is not in any teams
This person is not in any offices